Infrequent somatic mutations of the ICAT gene in various human cancers with frequent 1p-LOH and/or abnormal nuclear accumulation of β-catenin

Oncology Reports

Volumn 12, Issue 5, 2004, Pages 1099-1103

  Imai, Mitsuho ^a   Nakamura, Tsutomu ^b   Akiyama, Tetsu ^b   Horii, Akira ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

1p36; ICAT; Wnt signalling; catenin

Indexed keywords

BETA CATENIN; CELL CYCLE PROTEIN; CTNNB1 PROTEIN, HUMAN; CTNNBIP1 PROTEIN, HUMAN; CYTOSKELETON PROTEIN; REPRESSOR PROTEIN; SIGNAL PEPTIDE; TRANSACTIVATOR PROTEIN;

ARTICLE; CELL CULTURE; CELL NUCLEUS; CHROMOSOME 1; GENE EXPRESSION REGULATION; GENETICS; HETEROZYGOSITY LOSS; HUMAN; MUTATION; NEOPLASM; NUCLEOTIDE SEQUENCE; PATHOLOGY; POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM;

BETA CATENIN; CELL CYCLE PROTEINS; CELL NUCLEUS; CHROMOSOMES, HUMAN, PAIR 1; CYTOSKELETAL PROTEINS; DNA MUTATIONAL ANALYSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LOSS OF HETEROZYGOSITY; MUTATION; NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; REPRESSOR PROTEINS; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 16544362495     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.12.5.1099     Document Type: Article

References (58)

1. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B and Clevers H: Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/- colon carcinoma. Science 275: 1784-1787, 1997. (Pubitemid 27136714)
2. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B and Kinzler KW: Activation of β-catenin-Tcf signalling in colon cancer by mutations in β-catenin or APC. Science 275: 1787-1790, 1997. (Pubitemid 27136715)
3. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E and Polakis P: Stabilization of β-catenin by genetic defects in melanoma cell lines. Science 275: 1790-1792, 1997. (Pubitemid 27136716)
4. Satoh S, Daigo Y, Fumkawa Y, Kato T, Miwa N, Nishiwaki T, Kawasoe T, Ishiguro H, Fujita M, Tokino T, Sasaki Y, Imaoka S, Murata M, Shimano T, Yamaoka Y and Nakamura Y: AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 24: 245-250, 2000. (Pubitemid 30132191)
5. Fukuchi T, Sakamoto M, Tsuda H, Maruyama K, Nozawa S and Hirohashi S: β-catenin mutation in carcinoma of the uterine endometrium. Cancer Res 58: 3526-3528, 1998. (Pubitemid 28376543)
6. Garcia-Rostan G, Tallini G, Herrero A, D'Aquila TG, Carcangiu ML and Rimm DL: Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma. Cancer Res 59: 1811-1815, 1999. (Pubitemid 29186147)
7. Tago K, Nakamura T, Nishita M, Hyodo J, Nagai S, Murata Y, Adachi S, Ohwada S, Morishita Y, Shibuya H and Akiyama T: Inhibition of Wnt signaling by ICAT, a novel beta-catenin-interacting protein. Genes Dev 14: 1741-1749, 2000. (Pubitemid 30602993)
8. Daniels DL and Weis WI: ICAT inhibits β-catenin binding to Tcf/Lef-family transcription factors and the general coactivator p300 using independent structural modules. Mol Cell 10: 573-584, 2002. (Pubitemid 35291069)
9. Chen LC, Kurisu W, Ljung BM, Goldman ES, Moore D II and Smith HS: Heterogeneity for allelic loss in human breast cancer. J Natl Cancer Inst 84: 506-510, 1992.
10. Ezaki T, Yanagisawa A, Ohta K, Aiso S, Watanabe M, Hibi T, Kato Y, Nakajima T, Ariyama T, Inazawa J, Nakamura Y and Horii A: Deletion mapping on chromosome 1p in well-differentiated gastric cancer. Br J Cancer 73: 424-428, 1996. (Pubitemid 26055309)
11. Gasparian AV, Laktionov KK, Belialova MS, Pirogova NA, Tatosyan AG and Zborovskaya IB: Allelic imbalance and instability of microsatellite loci on chromosome lp in human non-small cell lung cancer. Br J Cancer 77: 1604-1611, 1998. (Pubitemid 28230460)
12. Kimura M, Abe T, Sunamura M, Matsuno S and Horii A: Detailed deletion mapping on chromosome arm 12q in human pancreatic adenocarcinoma: identification of a 1-cm region of common allelic loss. Genes Chromosomes Cancer 17: 88-93, 1996. (Pubitemid 26395526)
13. Han S, Semba S, Abe T, Makino N, Furukawa T, Fukushige S, Takahashi H, Sakurada A, Sato M, Shiiba K, Matsuno S, Nimura Y, Nakagawara A and Horii A: Infrequent somatic mutations of the p73 gene in various human cancers. Eur J Surg Oncol 25: 194-198, 1999. (Pubitemid 29182464)
14. Anger B, Bockman R, Andreeff M, Erlandson R, Jhanwar S, Kameya T, Saigo P, Wright W, Beattie EJ Jr, Oettgen HF and Old LJ: Characterization of two newly established human cell lines from patients with large cell anaplastic lung carcinoma. Cancer 50: 1518-1529, 1982. (Pubitemid 12034546)
15. Taya Y, Hosogai K, Hirohashi S, Shimosato Y, Tsuchiya R, Tsuchida N, Fushimi M, Sekiya T and Nishimura S: A novel combination of K-ras and myc amplification accompanied by point mutational activation of K-ras in a human lung cancer. EMBO J 3: 2943-2946, 1984.
16. Appelhans B, Ender B, Sachse G, Nikiforov T, Appelhans H and Ebert W: Secretion of antileucoprotease from a human lung tumor cell line. FEBS Lett 224: 14-18, 1987. (Pubitemid 17159985)
17. Imanishi K, Yamaguchi K, Kuranami M, Kyo E, Hozumi T and Abe K: Inhibition of growth of human lung adenocarcinoma cell lines by anti-transforming growth factor-alpha monoclonal antibody. J Natl Cancer Inst 81: 220-223, 1989. (Pubitemid 19044466)
18. Kobayashi S, Inaba H, Okada S and Nakada T: Culture and changes in dynamics of proliferation of pulmonary small cell carcinoma cells. Tohoku J Exp Med 159: 1-14, 1989. (Pubitemid 19276141)
19. Yoshioka S: Studies on thiol protease inhibitor isolation from human lung cancer cell line. Hiroshima J Med Sci 37: 199-215, 1989.
20. Erdel M, Peter W, Spiess E, Trefz G and Ebert W: Karyotypic characterization of established cell lines derived from a squamous cell carcinoma and adenocarcinoma of human lung cancers. Cancer Genet Cytogenet 49: 185-198, 1990. (Pubitemid 20372133)
21. Hirai K, Shimada H, Ogawa T and Taji S: The spread of human lung cancer cells on collagen and its inhibition by type III collagen. Clin Exp Metastasis 9: 517-527, 1991.
22. Mitsuhashi Y, Inaba M, Sugiyama Y and Kobayashi T: In vitro measurement of chemosensitivity of human small cell lung and gastric cancer cell lines toward cell cycle phase-non-specific agents under the clinically equivalent area under the curve. Cancer 70: 2540-2546, 1992.
23. Kobayashi S, Okada S, Yashida H, Hasumi T, Sato N, Inaba H, Nakada T and Fujimura S: Syalil-SSEA1 (SLX) levels in supernatant of cultured human lung carcinoma cell lines. Tohoku J Exp Med 173: 217-229, 1994.
24. Yamashita J, Tashiro K, Yoneda S, Kawahara K and Shirakusa T: Local increase in polymorphonuclear leukocyte elastase is associated with tumor invasiveness in non-small cell lung cancer. Chest 109: 1328-1334, 1996. (Pubitemid 26145673)
25. Takaki T, Hiraki A, Uenaka A, Gomi S, Itoh K, Udono H, Shibuya A, Tsuji T, Sekiguchi S and Nakayama E: Variable expression on lung cancer cell lines of HLA-A2-binding MAGE-3 peptide recognized by cytotoxic T lymphocytes. Int J Oncol 12: 1103-1109, 1998. (Pubitemid 28186774)
26. Takeshita H, Sato M, Shiwaku HO, Semba S, Sakurada A, Hoshi M, Hayashi Y, Tagawa Y, Ayabe H and Horii A: Expression of the DMBT1 gene is frequently suppressed in human lung cancer. Jpn J Cancer Res 90: 903-908, 1999. (Pubitemid 29500426)
27. Nishida M, Kasahara K, Oki A, Satoh T, Arai Y and Kubo T: Establishment of eighteen clones of Ishikawa cells. Hum Cell 9: 109-116, 1996.
28. Motoyama T, Hojo H and Watanabe H: Comparison of seven cell lines derived from human gastric carcinomas. Acta Pathol Jpn 36: 65-83, 1986. (Pubitemid 16187837)
29. Yokota J, Yamamoto T, Miyajima N, Toyoshima K, Nomura N, Sakamoto H, Yoshida T, Terada M and Sugimura T: Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue. Oncogene 2: 283-287, 1988. (Pubitemid 18085309)
30. Imanishi K, Yamaguchi K, Suzuki M, Honda S, Yanaihara N and Abe K: Production of transformation growth factor-alpha in human tumor cell lines. Br J Cancer 59: 761-765, 1989. (Pubitemid 19148540)
31. Nakatani H, Sakamoto H, Yoshida T, Yokota J, Tahara E, Sugimura T and Terada M: Isolation of an amplified DNA sequence in stomach cancer. Jpn J Cancer Res 81: 707-710, 1990. (Pubitemid 20246912)
32. Chen WH, Horoszewicz JS, Leong SS, Shimano T, Penetrante R, Sanders WH, Berjian R, Douglass HO, Martin EW and Chu TM: Human pancreatic adenocarcinoma: in vitro and in vivo morphology of a new tumor line established from ascites. In Vitro 18: 24-34, 1982. (Pubitemid 12116070)
33. Kobari M, Hisano H, Matsuno S, Sato T, Kan M and Tachibana T: Establishment of six human pancreatic cancer cell lines and their sensitivities to anti-tumor drugs. Tohoku J Exp Med 150: 231-248, 1986. (Pubitemid 17234977)
34. Takahashi T, Ishikura H, Iwai K, Takahashi C, Kato H, Tanabe T and Yoshiki T: Cytokine regulation of cell-to-cell interactions in lymphokine-activated killer cell cytotoxicity in vitro. Cancer Immunol Immunother 36: 76-82, 1993. (Pubitemid 23026410)
35. Kijima H, Abe Y, Yamazaki H, Ohnishi Y, Ueyama Y, Tamaoki N and Nakamura M: Stability of ras oncogene mutation in the human tumor xenografts through serial passages. Anticancer Res 14: 2583-2587, 1994.
36. a antigen. Int J Cancer 69: 290-294, 1996.
37. Fukushige S, Waldman F, Kimura M, Abe T, Furukawa T, Sunamura M, Kobari M and Horii A: Frequent gain of copy number on the long arm of chromosome 20 in human pancreatic adenocarcinoma. Genes Chromosome Cancer 19: 161-169, 1997. (Pubitemid 27278803)
38. Kimura M, Furukawa T, Abe T, Yatsuoka T, Youssef EM, Yokoyama T, Ouyang H, Ohnishi Y, Sunamura M, Kobari M, Matsuno S and Horii A: Identification of two common regions of allelic loss in chromosome arm 12q in human pancreatic cancer. Cancer Res 58: 2456-2460, 1998. (Pubitemid 28252709)
39. Fujimori K, Ohotomo H, Doi H, Watanabe M, Nakashima N, Ohkohchi N and Satomi S: Establishment and characterization for a human anaplastic thyroid carcinoma cell line. Thyroid Clin Exp 10: 131-135, 1998.
40. Komoike Y, Tamaki Y, Sakita I, Tomita N, Ohue M, Sekimoto M, Miyazaki M, Kadota M, Masuda N, Ooka M, Ohnishi T, Nakano Y, Kozaki T, Kobayashi T, Matsuura N, Ikeda T, Horii A and Monden M: Comparative genomic hybridization defines frequent loss on 16p in human anaplastic thyroid carcinoma. Int J Oncol 14: 1157-1162, 1999.
41. Suzuki A, Shao X, Song XQ, Hanaoka T, Irie S, Kashiwada M, Ghassan S, Close LG, Aoki T, Fujimori M, Ishikawa Y, Hatori M, Hosaka M, Sakurada A, Sato M, Ohuchi N, Satomi S, Fukushige S, Horii A and Sato T: Identification of a 5-cm region of common allelic loss on 8p12-p21 in human breast cancer and genomic analysis of the hEXT1L/EXTR1/EXTL3 gene in this locus. Int J Oncol 15: 443-451, 1999.
42. Matsuzaki M, Nagase S, Abe T, Miura K, Shiiba K, Sunamura M and Horii A: Detailed deletion mapping on chromosome 1p32-p36 in human colorectal cancer: identification of three distinct regions of common allelic loss. Int J Oncol 13: 1229-1233, 1998. (Pubitemid 28551549)
43. Mori Y, Matsunaga M, Abe T, Fukushige S, Miura K, Sunamura M, Shiiba K, Sato M, Nukiwa T and Horii A: Chromosome band 16q24 is frequently deleted in human gastric cancer. Br J Cancer 80: 556-562, 1999. (Pubitemid 29213213)
44. Semba S, Han SY, Ikeda H and Horii A: Frequent nuclear accumulation of B-catenin (CTNNB1) in human pituitary adenoma. Cancer 91: 42-48, 2001. (Pubitemid 32052612)
45. Sakurada A, Hamada H, Fukushige S, Yokoyama T, Yoshinaga K, Furukawa T, Sato S, Yajima A, Sato M, Fujimura S and Horii A: Adenovirus-mediated delivery of the PTEN gene inhibits cell growth by induction of apoptosis in endometrial cancer. Int J Oncol 15: 1069-1074, 1999.
46. Furukawa T, Yatsuoka T, Youssef EM, Abe T, Yokoyama T, Fukushige S, Soeda E, Hoshi M, Hayashi Y, Sunamura M, Kobari M and Horii A: Genomic analysis of DUSP6, a dual specificity MAP kinase phosphatase, in pancreatic cancer. Cytogenet Cell Genet 82: 156-159, 1998. (Pubitemid 29002456)
47. Sambrook J, Fritsch EF and Maniatis T: Isolation of DNA from mammalian cells: protocol I. In: Molecular Cloning: A Laboratory Manual. 2nd edition. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp9.16-9.21, 1989.
48. Orita M, Suzuki Y, Sekiya T and Hayashi K: Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5: 874-879, 1989.
49. Mayama T, Mori T, Abe K, Sasano H, Nishihira T and Horii A: Analysis of the p53 gene mutations in patients with multiple primary cancers of the esophagus. Eur J Surg Oncol 23: 298-303, 1997. (Pubitemid 27423499)
50. Sakurada A, Suzuki A, Sato M, Yamakawa H, Orikasa K, Uyeno S, Ono T, Ohuchi N, Fujimura S and Horii A: Infrequent genetic alterations of the PTEN/MMAC1 gene in Japanese patients with primary cancers of the breast, lung, pancreas, kidney, and ovary. Jpn J Cancer Res 88: 1025-1028, 1997. (Pubitemid 28021472)
51. Chen YZ, Hayashi Y, Wu JG, Takaoka E, Maekawa K, Watanabe N, Inazawa J, Hosoda F, Arai Y, Ohki M, Mizushima H, Morohashi A, Ohira M, Nakagawara A, Liu SY, Hoshi M, Horii A and Soeda E: A BAC-based STS-content map spanning a 35-Mb region of human chromosome 1p35-p36. Genomics 74: 55-70, 2001. (Pubitemid 32500266)
52. Koyama T, Tago K, Nakamura T, Ohwada S, Morishita Y, Yokota J and Akiyama T: Mutation and expression of the β-catenin-interacting protein ICAT in human colorectal tumors. Jpn J Clin Oncol 32: 358-362, 2002. (Pubitemid 43102789)
53. 2 arrest and cell death in tumor cell mutants for Ademonatous Polyposis Coli, β-catenin, or Axin. Cancer Res 62: 3322-3326, 2002.
54. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F and Caput D: Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90: 809-819, 1997. (Pubitemid 27357971)
55. Piao Z, Fang W, Malkhosyan S, Kim H, Horii A, Perucho M and Huang S: Frequent frameshift mutations of RIZ in sporadic gastrointestinal and endometrial carcinomas with microsatellite instability. Cancer Res 60: 4701-4704, 2000.
56. Sakurada K, Furukawa T, Kato Y, Kayama T, Huang S and Horii A: RIZ, the retinoblastoma protein interacting zinc finger gene, is mutated in genetically unstable cancers of the pancreas, stomach, and colorectum. Genes Chromosomes Cancer 30: 207-211, 2001. (Pubitemid 32044603)
57. Li QL, Ito K, Sakakura C, Fukamachi H, Inoue K, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, Kim HM, Kim WJ, Yamamoto H, Yamashita N, Yano T, Ikeda T, Itohara S, Inazawa J, Abe T, Hagiwara A, Yamagishi H, Ooe A, Kaneda A, Sugimura T, Ushijima T, Bae SC and Ito Y: Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109: 113-124, 2002. (Pubitemid 34327521)
58. Ariyama T, Inazawa J, Ezaki T, Nakamura Y, Horii A and Abe T: High-resolution cytogenetic mapping of the short arm of chromosome 1 with newly isolated 411 cosmid markers by fluorescence in situ hybridization: the precise order of 18 markers on 1p36.1 on prophase chromosomes and 'stretched' DNAs. Genomics 25: 114-123, 1995.